Valion Bio, Inc. - 8-K Filing
Valion Bio stockholders approved an increase in the share reserve for its equity incentive plan by 2,581,608 shares at their May 28, 2026 annual meeting. The amendment raised the total authorized shares under the plan to 3,219,566 and was previously approved by the board on January 29, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 below, on May 28, 2026, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Valion Bio, Inc, 9.01 Financial Statements and Exhibits)
Tickers: $TIVC